Table 3.
Frequency of baseline inflammatory markers and reproductive sequelae by PmpD antibody expression.
| Inflammation and sequelae | PmpD | ||
|---|---|---|---|
| No n = 10 |
Yes n = 30 |
P value | |
| Inflammation | |||
|
| |||
| aElevated temperature (>100.4°F) | 0 (0.0) | 1 (3.7) | 0.7500 |
| aElevated WBC count (>10,000 mm3) | 2 (20.0) | 8 (27.6) | 0.3038 |
| Erythrocyte sedimentation rate (>15 mm/hr) | 3 (30.0) | 10 (33.3) | 0.2996 |
| aC-reactive protein (>5 mg/dL) | 2 (40.0) | 6 (54.6) | 0.3590 |
| Bilateral adnexal tenderness | 7 (70.0) | 25 (83.3) | 0.2224 |
| aMucopurulent cervicitis | 4 (50.0) | 19 (70.4) | 0.1862 |
| Upper genital tract infection | 4 (50.0) | 17 (70.8) | 0.1878 |
| aEndometritis | 3 (33.3) | 15 (55.6) | 0.1609 |
|
| |||
| Reproductive sequelae | |||
|
| |||
| Infertility | 1 (10.0) | 4 (13.3) | 0.4165 |
| bLive birth | 7 (77.8) | 13 (65.0) | 0.2787 |
| Pregnancy | 8 (80.0) | 24 (80.0) | 1.000 |
| bChronic pelvic pain | 4 (44.4) | 9 (30.0) | 0.2219 |
| bRecurrent PID | 2 (22.2) | 4 (13.3) | 0.3024 |
aWBC data was available for 39 patients, CRP data was available for 16 patients, mucopurulent cervicitis data was available for 35 patients, UGTI data was available for 36 patients, and endometritis data was available for 32 patients; b live birth data was available for 29 patients; chronic pelvic pain and recurrent PID data were available for 39 patients.